Assessing the impact of weight loss and blood sugar control in people with type 2 diabetes

  • Post author:
  • Post category:uncategorized

A Cleveland Clinic research team has published the first study assessing the independent real-world impacts of weight loss and blood sugar control on clinical outcomes in people with type 2 diabetes treated with antidiabetic medications, and specifically with GLP-1RAs (the class of drug that includes Ozempic and Wegovy).